BCTX BRIACELL THERAPEUTICS CORP Investments/Divestments 8-K Filing 2023 - Agreement and Stock Purchase BriaCell Therapeutics Corp. entered into a Master Service and Technology Agreement with Prevail InfoWorks for clinical services and technologies for a breast cancer study, and also entered into a stock purchase agreement with Prevail Partners for the issuance of common shares.Get access to all SEC 8-K filings of the BRIACELL THERAPEUTICS CORP